DFTX director receives new RSU and option awards
Definium Therapeutics director Roger Adsett reported equity awards consisting of 3,555 common shares in the form of restricted stock units and 14,620 stock options.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Definium Therapeutics director Roger Adsett reported equity awards consisting of 3,555 common shares in the form of restricted stock units and 14,620 stock options. The options carry an exercise price of $24.11 per share and expire on June 10, 2036.
Both the RSUs and options vest as to 1/12 of the underlying shares on each monthly anniversary of the grant date, with any remaining unvested portion vesting immediately before the issuer’s next annual meeting if it occurs before the first anniversary, subject to his continued service. Following these grants, Adsett holds 3,555 common shares and 14,620 options directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 14,620 | $0.00 | $0.00 |
| Grant/Award | Common Shares | 3,555 | $0.00 | $0.00 |
Footnotes (2)
- F1. These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant, provided, that if the Issuer's annual meeting immediately following the date of grant takes place prior to the first anniversary of the date of grant, any unvested RSUs will vest immediately prior to the Issuer's annual meeting following the date of grant, subject the Reporting Person's continued service through the applicable vesting date.
- F2. The Stock Option vests and becomes exercisable as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant, provided, that if the Issuer's annual meeting immediately following the date of grant takes place prior to the first anniversary of the date of grant, the Stock Option will vest and become exercisable immediately prior to the Issuer's annual meeting following the date of grant, subject to the Reporting Person's continued service through the applicable vesting date.
Key Figures
Key Terms
restricted stock units ("RSUs") financial
Stock Option financial
vest financial
exercise price financial
annual meeting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did DFTX director Roger Adsett report on this Form 4?
What are the key terms of Roger Adsett’s stock options in Definium Therapeutics (DFTX)?
How do the RSUs granted to Roger Adsett by Definium Therapeutics (DFTX) vest?
Are Roger Adsett’s Form 4 transactions in DFTX open‑market buys or sells?
AI-generated analysis. How Rhea-AI works. Not financial advice.